MoneyWorks4Me

Anlon Healthcare submits analyst meet intimation

18 Mar 2026 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulation) read with part A of Schedule III of the Regulations, Anlon Healthcare has informed that the Punikumar Rasadia, Chairman and Managing Director of the Company will be interacting with the following Analyst(s)/ Investor(s) on Saturday, March 21, 2026 as per the details enclosed. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..